Cancer Biomarkers

译名:癌症生物标志物

SCIEJCR Q4中科院4区
预警期刊

1-3

2026

影响因子区间

平台估算

投稿周期

53%

2025

中国作者发文占比

1800 EUR

费用说明

收费

期刊简介:Concentrating on molecular biomarkers in cancer research, Cancer Biomarkers publishes original research findings (and reviews solicited by the editor) on the subject of the identification of markers associated with the disease processes whether or not they are an integral part of the pathological lesion.The disease markers may include, but are not limited to, genomic, epigenomic, proteomics, cellular and morphologic, and genetic factors predisposing to the disease or indicating the occurrence of the disease. Manuscripts on these factors or biomarkers, either in altered forms, abnormal concentrations or with abnormal tissue distribution leading to disease causation will be accepted.

【译文】专注于癌症研究中的分子生物标志物,癌症生物标志物期刊发表关于识别与疾病过程相关的标志物的研究成果(包括编辑邀请的评论)。这些疾病标志物可能包括但不限于基因组、表观基因组、蛋白质组学、细胞和形态学以及遗传因素,这些因素可能使疾病易感或指示疾病的发生。接受关于这些因素或生物标志物的研究论文,无论它们是改变形式、异常浓度还是异常组织分布导致疾病的原因。

出版社
IOS Press
语言
English
学科
医学
ISSN
1574-0153
eISSN
1875-8592
出版频率
双月刊
创刊年份
2005
投稿网址
https://www.editorialmanager.com/CBM
最近更新
2026-04-02 18:16:40
Cancer Biomarkers

指标当前值近三年趋势
JCR分区Q4
暂无
中科院分区4区
暂无
影响因子区间1-3
暂无